Eiger Pharmaceuticals

The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Merck discard jumps straight to the top of the chart of the most expensive drugs in the US at $1M-plus
Endpoints
Mon, 03/8/21 - 09:24 pm
Eiger Pharmaceuticals
Merck
progeria
Prokinvy